Amgen
Trade Amgen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.
AMGN Key Statistics
Stock Snapshot
With a market cap of 197.2B, Amgen(AMGN) trades at $365.00. The stock has a price-to-earnings ratio of 25.73 and currently yields dividends of 2.6%.
During the trading session on 2026-02-05, Amgen(AMGN) shares reached a daily high of $368.74 and a low of $330.00. At a current price of $365.00, the stock is +10.6% higher than the low and still -1.0% under the high.
Trading volume for Amgen(AMGN) stock has reached 5.9M, versus its average volume of 3.13M.
Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $368.75 and a low of $261.43.
Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $368.75 and a low of $261.43.
AMGN News
If you are wondering whether Amgen's current share price gives you fair value for your money, this article will walk through what the numbers say and where valu...
U.S. stock markets closed mixed on Wednesday as sector rotation by market participants continued. Investors remained concerned about the significantly overstret...
On Feb. 4, 2026, AMD’s AI-chip stumble rattled the Nasdaq while defensive Dow names steadied a suddenly nervous Wall Street. The S&P 500 (^GSPC 0.51%) fell 0.5...
Analyst ratings
48%
of 33 ratingsMore AMGN News
Amgen Inc (AMGN) announced an update on their ongoing clinical study. Amgen’s latest update on its FORTITUDE-301 trial offers investors a clearer view of the c...
Amgen Inc (NASDAQ:AMGN) reported better-than-expected fourth-quarter revenues and earnings, while witnessing "strength across key drivers (Repatha, Uplizna), ev...
In early trading on Wednesday, shares of Amgen topped the list of the day's best performing Dow Jones Industrial Average components, trading up 3.4%. Year to da...
RBC Capital raised the firm’s price target on Amgen (AMGN) to $360 from $335 and keeps an Outperform rating on the shares. The company reported strong Q4 on bot...
TD Cowen raised the firm’s price target on Amgen (AMGN) to $420 from $389 and keeps a Buy rating on the shares. The firm updated its model following Q4 results...
Amgen (NasdaqGS:AMGN) has ended its collaboration with Kyowa Kirin on the eczema drug rocatinlimab. Rights to develop and commercialize rocatinlimab have been...
Analyst Geoff Meacham from Citi maintained a Hold rating on Amgen and keeping the price target at $315.00. Geoff Meacham has given his Hold rating due to a com...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.